A new drug that prompts cancer cells to self-destruct while sparing healthy cells is now entering phase I clinical trials in humans. The drug, called PAC-1, first showed promise in the treatment of pet dogs with spontaneously occurring cancers, and is still in clinical trials in dogs with osteosarcoma.
More than half of patients with symptoms of mental illness – and nearly one-third of those who also had diabetes – said their health care providers had never told them to exercise or reduce their intake of dietary fat, according to a new study published in Diabetes Educator.
When exposed to nitrogen fertilizer over a period of years, nitrogen-fixing bacteria called rhizobia evolve to become less beneficial to legumes – the plants they normally serve, researchers report in a new study.
The people most often cited as “education experts” in blogs and news stories may have the backing of influential organizations – but have little background in education and education policy, a new study suggests.
No sector of the economy was left unscathed in the aftermath of the Great Recession, which officially lasted from December 2007 to June 2009 but whose aftereffects continue to linger today.
A group of international collaborators has found a way to deliver Ebola prevention information to people in every part of Sierra Leone - safely, and at negligible cost. The team is rolling out animated videos narrated in local languages that can be viewed on cell phones, tablets, computers and other digital devices.